Essential to increase the use of generics in Europe to maintain comprehensive health care?

Brian Godman, Marion Bennie, Christoph Baumgartel, Ljiljana Sović-Brkičić, Thomas Burkhardt, Jurij Fürst, Kristina Garuoliene, Miguel Gomes

Research output: Contribution to journalArticle

Abstract

Reforms have been introduced across Europe to increase prescribing efficiency with existing drugs. These include measures to lower prices of generics as well as increase their prescribing versus originators and patented products in a class or related class. This is essential to maintain comprehensive health care in Europe given continued pressures. The alternative is insufficient funds for new innovative drugs and increasing drug volumes with ageing populations. To review the influence of measures and initiatives to increase the prescribing and dispensing of generics at low prices on ambulatory care prescribing efficiency. In view of this, provide guidance as authorities strive to introduce further reforms to meet their goals. A narrative review of published papers combined with case histories. The different supply- and demand-side measures have reduced generic prices to as low as 2% to 3% of pre-patent loss prices in some cases as well as appreciably enhanced their utilisation. As a result, prescribing efficiency has increased without compromising care. In some cases, the reforms have led to expenditure actually falling despite appreciably increased volumes. Increasing use of generics at low prices will help maintain the European ideals of comprehensive and equitable health care. However, countries will continually need to learn from each other.
LanguageEnglish
Pages5-20
Number of pages16
JournalFarmeconomia : Health Economics and Therapeutic Pathways
Volume13
Issue number3S
Publication statusPublished - 2012

Fingerprint

Comprehensive Health Care
Pharmaceutical Preparations
Financial Management
Ambulatory Care
Health Expenditures
Pressure
Population

Keywords

  • generics
  • health care
  • innovative drugs

Cite this

Godman, B., Bennie, M., Baumgartel, C., Sović-Brkičić, L., Burkhardt, T., Fürst, J., ... Gomes, M. (2012). Essential to increase the use of generics in Europe to maintain comprehensive health care? Farmeconomia : Health Economics and Therapeutic Pathways, 13(3S), 5-20.
Godman, Brian ; Bennie, Marion ; Baumgartel, Christoph ; Sović-Brkičić, Ljiljana ; Burkhardt, Thomas ; Fürst, Jurij ; Garuoliene, Kristina ; Gomes, Miguel. / Essential to increase the use of generics in Europe to maintain comprehensive health care?. In: Farmeconomia : Health Economics and Therapeutic Pathways. 2012 ; Vol. 13, No. 3S. pp. 5-20.
@article{8ab6b743a533402789ccf8a26c4eaca3,
title = "Essential to increase the use of generics in Europe to maintain comprehensive health care?",
abstract = "Reforms have been introduced across Europe to increase prescribing efficiency with existing drugs. These include measures to lower prices of generics as well as increase their prescribing versus originators and patented products in a class or related class. This is essential to maintain comprehensive health care in Europe given continued pressures. The alternative is insufficient funds for new innovative drugs and increasing drug volumes with ageing populations. To review the influence of measures and initiatives to increase the prescribing and dispensing of generics at low prices on ambulatory care prescribing efficiency. In view of this, provide guidance as authorities strive to introduce further reforms to meet their goals. A narrative review of published papers combined with case histories. The different supply- and demand-side measures have reduced generic prices to as low as 2{\%} to 3{\%} of pre-patent loss prices in some cases as well as appreciably enhanced their utilisation. As a result, prescribing efficiency has increased without compromising care. In some cases, the reforms have led to expenditure actually falling despite appreciably increased volumes. Increasing use of generics at low prices will help maintain the European ideals of comprehensive and equitable health care. However, countries will continually need to learn from each other.",
keywords = "generics, health care, innovative drugs",
author = "Brian Godman and Marion Bennie and Christoph Baumgartel and Ljiljana Sović-Brkičić and Thomas Burkhardt and Jurij F{\"u}rst and Kristina Garuoliene and Miguel Gomes",
year = "2012",
language = "English",
volume = "13",
pages = "5--20",
journal = "Farmeconomia : Health Economics and Therapeutic Pathways",
issn = "1721-6915",
number = "3S",

}

Godman, B, Bennie, M, Baumgartel, C, Sović-Brkičić, L, Burkhardt, T, Fürst, J, Garuoliene, K & Gomes, M 2012, 'Essential to increase the use of generics in Europe to maintain comprehensive health care?' Farmeconomia : Health Economics and Therapeutic Pathways, vol. 13, no. 3S, pp. 5-20.

Essential to increase the use of generics in Europe to maintain comprehensive health care? / Godman, Brian; Bennie, Marion; Baumgartel, Christoph; Sović-Brkičić, Ljiljana; Burkhardt, Thomas; Fürst, Jurij; Garuoliene, Kristina; Gomes, Miguel.

In: Farmeconomia : Health Economics and Therapeutic Pathways, Vol. 13, No. 3S, 2012, p. 5-20.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Essential to increase the use of generics in Europe to maintain comprehensive health care?

AU - Godman, Brian

AU - Bennie, Marion

AU - Baumgartel, Christoph

AU - Sović-Brkičić, Ljiljana

AU - Burkhardt, Thomas

AU - Fürst, Jurij

AU - Garuoliene, Kristina

AU - Gomes, Miguel

PY - 2012

Y1 - 2012

N2 - Reforms have been introduced across Europe to increase prescribing efficiency with existing drugs. These include measures to lower prices of generics as well as increase their prescribing versus originators and patented products in a class or related class. This is essential to maintain comprehensive health care in Europe given continued pressures. The alternative is insufficient funds for new innovative drugs and increasing drug volumes with ageing populations. To review the influence of measures and initiatives to increase the prescribing and dispensing of generics at low prices on ambulatory care prescribing efficiency. In view of this, provide guidance as authorities strive to introduce further reforms to meet their goals. A narrative review of published papers combined with case histories. The different supply- and demand-side measures have reduced generic prices to as low as 2% to 3% of pre-patent loss prices in some cases as well as appreciably enhanced their utilisation. As a result, prescribing efficiency has increased without compromising care. In some cases, the reforms have led to expenditure actually falling despite appreciably increased volumes. Increasing use of generics at low prices will help maintain the European ideals of comprehensive and equitable health care. However, countries will continually need to learn from each other.

AB - Reforms have been introduced across Europe to increase prescribing efficiency with existing drugs. These include measures to lower prices of generics as well as increase their prescribing versus originators and patented products in a class or related class. This is essential to maintain comprehensive health care in Europe given continued pressures. The alternative is insufficient funds for new innovative drugs and increasing drug volumes with ageing populations. To review the influence of measures and initiatives to increase the prescribing and dispensing of generics at low prices on ambulatory care prescribing efficiency. In view of this, provide guidance as authorities strive to introduce further reforms to meet their goals. A narrative review of published papers combined with case histories. The different supply- and demand-side measures have reduced generic prices to as low as 2% to 3% of pre-patent loss prices in some cases as well as appreciably enhanced their utilisation. As a result, prescribing efficiency has increased without compromising care. In some cases, the reforms have led to expenditure actually falling despite appreciably increased volumes. Increasing use of generics at low prices will help maintain the European ideals of comprehensive and equitable health care. However, countries will continually need to learn from each other.

KW - generics

KW - health care

KW - innovative drugs

UR - http://journals.edizioniseed.it/index.php/FE/article/view/312

M3 - Article

VL - 13

SP - 5

EP - 20

JO - Farmeconomia : Health Economics and Therapeutic Pathways

T2 - Farmeconomia : Health Economics and Therapeutic Pathways

JF - Farmeconomia : Health Economics and Therapeutic Pathways

SN - 1721-6915

IS - 3S

ER -